Retatrutidepeptide
The TRAIL peptide, also known as Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) or Apo2L, is a critical signaling molecule that plays a significant role in programmed cell death, or apoptosis. This potent inducer of apoptosis preferentially targets cancer cells, making it a subject of intense research for potential cancer therapies.TRAIL Receptor-1 Human Recombinant Fc Understanding the function and applications of TRAIL peptide is essential for researchers and clinicians exploring novel strategies to combat various forms of cancer.
Understanding TRAIL Peptide and Its Mechanism
TRAIL is a cytokine belonging to the TNF superfamily. It exerts its function by binding to specific death receptors on the surface of target cells, primarily TRAIL-R1 and TRAIL-R2. This binding initiates a cascade of intracellular events that ultimately lead to apoptosisTRAIL-based gene delivery and therapeutic strategies. Crucially, TRAIL demonstrates a remarkable selectivity, inducing apoptosis in a wide array of cancer cells while largely sparing normal, healthy cells. This selective cytotoxicity is a highly desirable characteristic for therapeutic agents.
Beyond its direct action, TRAIL peptide is also recognized for its use in laboratory settings. It can function as a blocking peptide, employed in neutralization and control experiments to study antibody interactions or to specifically inhibit TRAIL-mediated signaling.TRAIL | Ligand page Furthermore, synthetic peptides that mimic TRAIL's structure are being developed as potential therapeutic agents themselves, aiming to harness the natural apoptotic pathways for cancer treatment.
TRAIL Peptide in Cancer Therapy Research
The selective induction of apoptosis in tumor cells by TRAIL peptide has positioned it as a promising candidate for cancer therapy. Researchers are actively investigating various approaches to leverage TRAIL's capabilities:
* Direct Therapeutic Use: While direct administration of TRAIL has faced challenges, such as short half-life and potential off-target effects, ongoing research focuses on developing more stable and effective TRAIL-based therapeutics, including recombinant TRAIL fusion proteinsTRAIL Proteins.
* Mimicking Peptides: The development of TRAIL-mimicking peptides offers an alternative strategy. These engineered peptides can effectively trigger the TRAIL death pathway, potentially leading to tumor regression.
* Gene Therapy: Gene transfer methods are also being explored, aiming to deliver the TRAIL gene or protein directly into cancer cells, thereby inducing apoptosis from within.
* Targeting TRAIL Receptors: Research also extends to understanding and modulating TRAIL receptors, such as TRAIL R3 (also known as CD263), which can act as an antagonist decoy receptor, inhibiting TRAIL-induced apoptosis.作者：NM Tripathi·2025—P is a solitary peptide ligand that mimics TRAIL(the natural ligand to death receptor) and is reported to control cancer growth in vivo ... Manipulating these receptor interactions could offer further therapeutic avenues.TRAIL binds to several TNF family receptors, activating MAPK8/JNK, caspase 8, and caspase 3. Its interaction with death receptors on tumor cells triggers ...
Applications and Variations
TRAIL peptide and its related molecules serve diverse purposes in biological research:
* Research Reagents: TRAIL peptides are widely used as blocking peptides for antibodies, as well as in experiments designed to study apoptosis pathways and receptor interactions. Various recombinant human and mouse TRAIL proteins are available for research applicationsHuman CD263 (TRAIL-R3) Synthetic Peptide (PEP-0084).
* Diagnostic and Investigative Tools: The ability of TRAIL to induce apoptosis makes it a valuable tool for understanding cancer biology and for developing diagnostic markers.
* Synthetic Analogs: Beyond full-length TRAIL, synthetic peptide fragments and analogs are synthesized for specific experimental needs or therapeutic development, such as the human CD253 (TRAIL) (aa 207-220) synthetic peptide.TRAIL Blocking Peptide for SAB3500424· SBP3500424-0.05MG · Properties · Description · Related Products · Safety Information · Documentation · Technical Service.
The study of TRAIL peptide continues to evolve, with ongoing efforts to enhance its therapeutic efficacy and broaden its applications in cancer treatment and fundamental biological research. Its selective cytotoxic properties and central role in apoptosis make it a cornerstone molecule in the quest for more effective cancer therapies.
Join the newsletter to receive news, updates, new products and freebies in your inbox.